239
Views
18
CrossRef citations to date
0
Altmetric
Articles

Factor Analytical Investigation of Krathom (Mitragyna speciosa Korth.) Withdrawal Syndrome in Thailand

, Ph.D., , M.D., Ph.D., , Ph.D. & , Ph.D.
Pages 76-85 | Received 29 Oct 2015, Accepted 01 Feb 2016, Published online: 25 Mar 2016

References

  • Administrative Committee of Substance Abuse Academic Network. 2011. Status of substance use in 2011: National household survey, estimation of population related with substance abuse. Hat Yai, Thailanda: Prince of Songkla University.
  • Ahmad, K., and K. Aziz. 2012. Mitragyna speciosa use in the northern states of Malaysia: A cross-sectional study. Journal of Ethnopharmacology 141 (1):446–50. doi:10.1016/j.jep.2012.03.009.
  • Allsop, D. J., M. M. Norberg, J. Copeland, S. Fu, and A. J. Budney. 2011. The Cannabis Withdrawal Scale development: Patterns and predictors of cannabis withdrawal and distress. Drug and Alcohol Dependence 119 (1–2):123–29. doi:10.1016/j.drugalcdep.2011.06.003.
  • American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders: DSM-V, 5th ed. Washington, DC: American Psychiatric Association.
  • Assanangkornchai, S. 2005. Pattern of krathom use, krathom addiction and its impact on health. In Krathom plant in Thai society: Culture, behavior, health, science, laws, eds. S. Assanangkornchai, A. Sirivongs, and N. Ayudhya, 130–43. Bangkok: Ministry of Justice.
  • Assanangkornchai, S., A. Muekthong, N. Sam-Angsri, and U. Pattanasattayawong. 2007. The use of Mitragynine speciosa (“Krathom”), an addictive plant, in Thailand. Substance Use and Misuse 42 (14):2145–57. doi:10.1080/10826080701205869.
  • Beckett, A. H., E. J. Shellard, J. D. Phillipson, and C. M. Lee. 1966. The Mitragyna species of Asia. VI. Oxindole alkaloids from the leaves of Mitragyna speciosa Korth. Planta Medica 14 (3):266–76. doi:10.1055/s-0028-1100054.
  • Boyer, E. W., K. M. Babu, J. E. Adkins, C. R. McCurdy, and J. H. Halpern. 2008. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa Korth). Addiction 103 (6):1048–50. doi:10.1111/add.2008.103.issue-6.
  • Chittrakarn, S., S. Assanangkornchai, E. Kumarnsit, J. Wungsintaweekul, P. Penjamras, W. Udomuksorn, and D. Saingam. 2016. Pharmacokinetic study and effects of kratom (Mitragyna speciosa Korth.) on electroencephalogram in healthy volunteers: An on-going research. Songkhla: Prince of Songkla University.
  • Chittrakarn, S., N. Keawpradub, K. Sawangjaroen, S. Kansenalak, and B. Janchawee. 2010. The neuromuscular blockade produced by pure alkaloid, mitragynine and methanol extract of kratom leaves (Mitragyna speciosa Korth.). Journal of Ethnopharmacology 129 (3):344–49. doi:10.1016/j.jep.2010.03.035.
  • Chittrakarn, S., P. Keawwongsri, E. Kumarnsit, K. Sawangjaroen, and N. Keawpradub. 2005. Botanical description and pharmacological activity. In Krathom plant in Thai society: Culture, behavior, health, science, laws, eds. S. Assanangkornchai, A. Sirivongs, and N. Ayudhya, 97–112. Bangkok, Thailand: Ministry of Justice.
  • Chongsuvivatwong, V. 2008. Analysis of epidemiological data using R and Epicalc. Songkhla, Thailand: Epidemiology Unit, Prince of Songkla University.
  • Chuchuen, C., B. Petcharat, S. Jitpiromsri, C. Phantusena, T. Intanont, and U. Pattanasattayawong. 2005. Definition, social and culture implication, and life style in community related to krathom use. In Krathom plant in Thai society: Culture, behavior, health, science, laws, eds. S. Assanangkornchai, A. Sirivongs, and N. Ayudhya, 19–95. Bangkok, Thailand: Ministry of Justice.
  • Elholm, B., K. Larsen, N. Hornnes, F. Zierau, and U. Becker. 2010. A psychometric validation of the Short Alcohol Withdrawal Scale (SAWS). Alcohol and Alcoholism 45 (4):361–65. doi:10.1093/alcalc/agq033.
  • Everitt, B. S. 1975. Multivariate analysis: The need for data and other problems. The British Journal of Psychiatry 126:237–40. doi:10.1192/bjp.126.3.237.
  • Fabrigar, L. R., D. T. Wegener, R. C. MacCallum, and E. J. Strahan. 1999. Evaluating the use of exploratory factor analysis in psychological research. Psychological Methods 4:272–99. doi:10.1037/1082-989X.4.3.272.
  • Handelsman, L., K. J. Cochrane, M. J. Aronson, R. Ness, K. J. Rubinstein, and P. D. Kanof. 1987. Two new rating scales for opiate withdrawal. The American Journal of Drug and Alcohol Abuse 13 (3):293–308. doi:10.3109/00952998709001515.
  • Hassan, Z., M. Muzaimi, V. Navaratnam, N. H. Yusoff, F. W. Suhaimi, R. Vadivelu, B. K. Vicknasingam, D. Amato, S. Von Horsten, N. I. Ismail, N. Jayabalan, A. I. Hazim, S. M. Mansor, and C. P. Muller. 2013. From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction. Neuroscience and Biobehavioral Reviews 37 (2):138–51. doi:10.1016/j.neubiorev.2012.11.012.
  • Havemann-Reinecke, U. 2011. P01-50-Kratom and alcohol dependence: Clinical symptoms, withdrawal treatment and pharmacological mechanisms: A case report. The Journal of the. European Psychiatric Association 26 (Suppl. 1):50. doi:10.1016/S0924-9338(11)71761-8.
  • Holler, J. M., S. P. Vorce, P. C. McDonough-Bender, J. Magluilo Jr., C. J. Solomon, and B. Levine. 2011. A drug toxicity death involving propylhexedrine and mitragynine. Journal of Analytical Toxicology 35 (1):54–59. doi:10.1093/anatox/35.1.54.
  • Jamil, M. F., M. F. Subki, T. M. Lan, M. I. Majid, and M. I. Adenan. 2013. The effect of mitragynine on cAMP formation and mRNA expression of mu-opioid receptors mediated by chronic morphine treatment in SK-N-SH neuroblastoma cell. Journal of Ethnopharmacology 148 (1):135–43. doi:10.1016/j.jep.2013.03.078.
  • Joreskog, K. G., and D. Sorbom. 1993. Structural equation modeling with the SIMPLIS command language. Mahwah, NJ: Lawrence Erlbaum Associates.
  • Kabacoff, R. I. 2012. Principal components and factor analysis. http://www.statmethods.net/advstats/factor.html ( accessed April 12, 2012).
  • Kaiser, H. F. 1974. An index of factorial simplicity. Psychometrika 39:31–36. doi:10.1007/BF02291575.
  • Kline, R. B. 2011. Principles and practice of structural equation modeling, 3rd ed. New York: The Guilford Press.
  • Matsumoto, K., S. Horie, H. Ishikawa, H. Takayama, N. Aimi, D. Ponglux, and K. Watanabe. 2004. Antinociceptive effect of 7-hydroxymitragynine in mice: Discovery of an orally active opioid analgesic from the Thai medicinal herb Mitragyna speciosa. Life Sciences 74 (17):2143–55. doi:10.1016/j.lfs.2003.09.054.
  • Matsumoto, K., M. Mizowaki, H. Takayama, S. Sakai, N. Aimi, and H. Watanabe. 1997. Suppressive effect of mitragynine on the 5-methoxy-N,N-dimethyltryptamine-induced head-twitch response in mice. Pharmacology, Biochemistry, and Behavior 57 (1–2):319–23. doi:10.1016/S0091-3057(96)00314-0.
  • McWhirter, L., and S. Morris. 2010. A case report of inpatient detoxification after kratom (Mitragyna speciosa) dependence. European Addiction Research 16 (4):229–31. doi:10.1159/000320288.
  • Neerman, M. F., R. E. Frost, and J. Deking. 2013. A drug fatality involving kratom. Journal of Forensic Sciences 58 (Suppl. 1):S278–9. doi:10.1111/1556-4029.12009.
  • Nelsen, J. L., Lapoint, J., Hodgman, M. J., and Aldous, K. M.. 2010. Seizure and coma following Kratom (Mitragynina speciosa Korth) exposure. Journal of medical toxicology 6 (4):424–6. doi:10.1007/s13181-010-0079-5.
  • Saingam, D., S. Assanangkornchai, A. F. Geater, and Q. Balthip. 2013. Pattern and consequences of krathom (Mitragyna speciosa Korth.) use among male villagers in southern Thailand: A qualitative study. The International Journal on Drug Policy 24 (4):351–58. doi:10.1016/j.drugpo.2012.09.004.
  • Saingam, D., S. Assanangkornchai, A. F. Geater, and S. Lerkiatbundit. 2014. Validation of Krathom (Mitragyna speciosa Korth.) Dependence Scale (KDS): A dependence screen for internationally emerging psychoactive substance. Substance Abuse 35:276–83. doi:10.1080/08897077.2014.924464.
  • Schmidt, M. M., A. Sharma, F. Schifano, and C. Feinmann. 2011. “Legal highs” on the net-evaluation of UK-based websites, products and product information. Forensic Science International 206 (1–3):92–97. doi:10.1016/j.forsciint.2010.06.030.
  • Schreiber, J. B., A. Nora, F. K. Stage, E. A. Barlow, and J. King. 2006. Reporting structural equation modeling and confirmatory factor analysis results: A review. The Journal of Educational Research 99:323–38. doi:10.3200/JOER.99.6.323-338.
  • Singh, D., C. P. Muller, and B. K. Vicknasingam. 2014. Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users. Drug and Alcohol Dependence 139:132–37. doi:10.1016/j.drugalcdep.2014.03.017.
  • Suwanlert, S. 1975. A study of kratom eaters in Thailand. Bulletin on Narcotics 27:21–27.
  • Thongpradichote, S., K. Matsumoto, M. Tohda, H. Takayama, N. Aimi, S. Sakai, and H. Watanabe. 1998. Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice. Life Sciences 62 (16):1371–78. doi:10.1016/S0024-3205(98)00075-7.
  • Tsuchiya, S., S. Miyashita, M. Yamamoto, S. Horie, S. Sakai, N. Aimi, H. Takayama, and K. Watanabe. 2002. Effect of mitragynine, derived from Thai folk medicine, on gastric acid secretion through opioid receptor in anesthetized rats. European Journal of Pharmacology 443 (1–3):185–88. doi:10.1016/S0014-2999(02)01588-1.
  • Vicknasingam, B., S. Narayanan, G. T. Beng, and S. M. Mansor. 2010. The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. The International Journal on Drug Policy 21 (4):283–88. doi:10.1016/j.drugpo.2009.12.003.
  • Watanabe, K., S. Yano, S. Horie, and L. T. Yamamoto. 1997. Inhibitory effect of mitragynine, an alkaloid with analgesic effect from Thai medicinal plant Mitragyna speciosa, on electrically stimulated contraction of isolated guinea-pig ileum through the opioid receptor. Life Sciences 60 (12):933–42. doi:10.1016/S0024-3205(97)00023-4.
  • Welsch, S. K., S. S. Smith, D. W. Wetter, D. E. Jorenby, M. C. Fiore, and T. B. Baker. 1999. Development and validation of the Wisconsin Smoking Withdrawal Scale. Experimental and Clinical Psychopharmacology 7 (4):354–61. doi:10.1037/1064-1297.7.4.354.
  • Yamamoto, L. T., S. Horie, H. Takayama, N. Aimi, S. Sakai, S. Yano, J. Shan, P. K. Pang, D. Ponglux, and K. Watanabe. 1999. Opioid receptor agonistic characteristics of mitragynine pseudoindoxyl in comparison with mitragynine derived from Thai medicinal plant. Mitragyna Speciosa. General Pharmacology 33 (1):73–81.
  • Yusoff, N. H., F. W. Suhaimi, R. K. Vadivelu, Z. Hassan, A. Rumler, A. Rotter, D. Amato, H. C. Dringenberg, S. M. Mansor, V. Navaratnam, and C. P. Muller. 2014. Abuse potential and adverse cognitive effects of mitragynine (kratom). Addiction Biology 21 (1):98–110. doi:10.1111/adb.12185.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.